Skip to content

Surgiprint: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Surgiprint

BE 0778.866.151
NACE 86.910, Medical imaging and medical laboratories
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€6,892
2024 · -€30,315+€23,423
Equity
€53,887
2024 · €60,779-€6,892
Cash
€52,233
2024 · €55,593-€3,360
Balance sheet total
€54,471
2024 · €61,833-€7,362

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€3,544

    down €3,544 (-78.0%), from €4,544 to €1,000

    of which Other amounts receivable: -€3,544

  • Cash -€3,360

    down €3,360 (-6.0%), from €55,593 to €52,233

    mainly Net result for the year (-€6,892) and Trade debts (-€554)

Equity and liabilities
  • Profit (loss) carried forward -€6,892

    down €6,892 (-16.5%), from -€41,721 to -€48,613

Income statement
  • Gross operating margin +€23,350

    up €23,350 (+79.7%), from -€29,282 to -€5,932

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€30,315
Gross operating margin +€23,350
Other operating charges +€87
Financial income -€0
Financial charges -€14
Result 2025 -€6,892
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€3,616
Investment +€257
Financing €0
Cash 2024 €55,593
Net result for the year -€6,892
Depreciation +€201
Receivables within one year +€3,544
Trade debts -€554
Tax, wage and social debts +€85
Investment in fixed assets (net) +€257
Cash 2025 €52,233
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €61,833 €54,471 -€7,362 -11.9%
Formation expenses 20 €396 €195 -€201 -50.8%
Fixed assets 21/28 €1,300 €1,043 -€257 -19.8%
Financial fixed assets 28 €1,300 €1,043 -€257 -19.8%
Current assets 29/58 €60,137 €53,233 -€6,904 -11.5%
Amounts receivable within one year 40/41 €4,544 €1,000 -€3,544 -78.0%
Trade receivables 40 €1,000 €1,000 = 0.0%
Other amounts receivable 41 €3,544 - -€3,544
Cash at bank and in hand 54/58 €55,593 €52,233 -€3,360 -6.0%
Total equity and liabilities 10/49 €61,833 €54,471 -€7,362 -11.9%
Equity 10/15 €60,779 €53,887 -€6,892 -11.3%
Contributions 10/11 €102,500 €102,500 = 0.0%
Profit (loss) carried forward 14 -€41,721 -€48,613 -€6,892 -16.5%
Amounts payable 17/49 €1,054 €585 -€469 -44.5%
Amounts payable within one year 42/48 €1,054 €585 -€469 -44.5%
Trade debts 44 €554 - -€554
Suppliers 440/4 €554 - -€554
Taxes, remuneration and social security 45 - €85 +€85
Taxes 450/3 - €85 +€85
Other amounts payable 47/48 €500 €500 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €201 €201 = 0.0%
Other operating charges 640/8 €576 €489 -€87 -15.2%
Gross operating margin 9900 -€29,282 -€5,932 +€23,350 +79.7%
Operating profit (loss) 9901 -€30,060 -€6,623 +€23,437 +78.0%
Financial income 75/76B €0 - -€0
Recurring financial income 75 €0 - -€0
Financial charges 65/66B €256 €270 +€14 +5.6%
Recurring financial charges 65 €256 €270 +€14 +5.6%
Profit (loss) for the period before taxes 9903 -€30,315 -€6,892 +€23,423 +77.3%
Profit (loss) for the period 9904 -€30,315 -€6,892 +€23,423 +77.3%
Profit (loss) for the period to be appropriated 9905 -€30,315 -€6,892 +€23,423 +77.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.